Strategies for management of cytomegalovirus (CMV) infection after allogeneic bone marrow transplantation: the "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment approaches
- PMID: 11547769
- DOI: 10.1182/blood.v98.5.1627
Strategies for management of cytomegalovirus (CMV) infection after allogeneic bone marrow transplantation: the "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment approaches
Comment on
-
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.Blood. 2001 Jan 15;97(2):388-92. doi: 10.1182/blood.v97.2.388. Blood. 2001. PMID: 11154213
-
Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes.Blood. 2001 Feb 15;97(4):867-74. doi: 10.1182/blood.v97.4.867. Blood. 2001. PMID: 11159510
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical